Brind.
  1. Citigroup and Raymond James Financial published research reports and price targets for a company whose stock trades on the Nasdaq platform.

Citigroup provided rating and price targets for ProQR Therapeutics stock.

1 report, 1 independent Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Citigroup provided rating and price targets for ProQR Therapeutics stock.

Who's involved

What this event is mainly about
Citigroup

Keep exploring

Part of

Citigroup and Raymond James Financial published research reports and price targets for a company whose stock trades on the Nasdaq platform.

Also in this story

All 4 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped